Clinical Trials

Inclusion Criteria:

• For patients aged 18 years or older experiencing mild symptoms of anxiety or depression and who have a GAD-7 score 5 and above.
• Patient should have smart phone and should be using Facebook, Instagram, Twitter, Tik Tok, and Pinterest social media apps.
• Patients should have email access.

Exclusion Criteria: 

• Any patient who uses a smartphone for tracking glucose for diabetes management, heart rate, or any chronic illness which is being managed through a smartphone app.
• Any patient who uses more than one personal smartphone
• Any patient who is a suicide risk as per PHQ-9 score, current recreational drug usage, or alcohol abuse.
• Any patient who has suicidal ideation as per PHQ-9 assessment before or during the study period will be excluded, (all patients will be monitored for suicidal ideation by PHQ-9 scoring method at day 1, week 6, and week 12, but it is the responsibility  of the patient to inform the study team if they have developed any suicidal ideation throughout the study period).
• Patients with activated POA (Power of Attorney - Healthcare), diagnosis of mental retardation or current disability due to any psychiatric disorder or severe depression with a high risk of suicide should be excluded.c
• Any patient currently undergoing ECT (electroconvulsive therapy) for severe depression.
• Any patient taking prescribed SSRIs/SNRIs, with a change and not taking them continuously in last 30 days (not a new diagnosis of anxiety). If change they will be excluded.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 1/24/24. Questions regarding updates should be directed to the study team contact.